Inactivated Polio And Rabies Vaccines Market Report 2026

Inactivated Polio And Rabies Vaccines Market Overview

• Inactivated Polio And Rabies Vaccines market size has reached to $2.27 billion in 2025 • Expected to grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 5.5% • Growth Driver: The Growing Demand For Effective Vaccination Programs Is Fueling The Growth Of The Market Due To Increasing Government Efforts And Global Health Initiatives • Market Trend: Advancement In Inactivated Rabies Vaccines Enhances Global Disease Prevention Efforts • North America was the largest region in 2025.

What Is Covered Under Inactivated Polio And Rabies Vaccines Market?

Inactivated polio and rabies vaccines (IPV) are designed to protect individuals from polio and rabies, respectively. Both vaccines are created using viruses that have been killed, ensuring they cannot cause disease. IPV prevents poliomyelitis, a viral condition that can lead to paralysis, while the inactivated rabies vaccine safeguards against rabies, a deadly infection typically transmitted through animal bites. These vaccines stimulate the immune system to provide durable protection without inducing illness. The main product types of inactivated polio and rabies vaccines are inactivated polio vaccine and inactivated rabies vaccine. Inactivated polio vaccine (IPV) is a safe, injected vaccine derived from inactivated poliovirus, used to boost immunity and protect against polio without causing infection. It is inactivated by using various methods, such as the solvent detergent method, radiation method, pH concentration, heat inactivation, and others, and is distributed through several distribution channels, including government and private, for different applications, including pediatrics and adults.

What Is The Inactivated Polio And Rabies Vaccines Market Growth Forecast?

The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to $2.97 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing focus on zero rabies deaths targets, growing pediatric immunization coverage in emerging economies, rising healthcare access in rural regions, expansion of adult post-exposure prophylaxis demand, strengthening pandemic preparedness infrastructure. Major trends in the forecast period include expansion of combination ipv and rabies immunization programs, shift toward intradermal rabies vaccination for dose optimization, strengthening of cold chain and vaccine logistics infrastructure, increasing government-led mass immunization campaigns, rising adoption of who-prequalified inactivated vaccines.

Global Inactivated Polio And Rabies Vaccines Market Segmentation

1) By Product Type: Inactivated Polio Vaccine, Inactivated Rabies Vaccine 2) By Method Of Inactivation: Solvent Detergent Method, Radiation Method, pH Concentration, Heat Inactivation, Other Method Of Inactivations 3) By Distribution Channel: Government, Private 4) By Application: Pediatrics, Adults Subsegments: 1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine, Oral Inactivated Polio Vaccine 2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine, Intradermal Inactivated Rabies Vaccine

What Is The Driver Of The Inactivated Polio And Rabies Vaccines Market?

The growing demand for effective vaccination programs is expected to propel the growth of the inactivated polio and rabies vaccines going forward. A vaccination program is a planned effort by a group or government to give people vaccines to help protect them from diseases. Rising vaccination programs stem from stronger government efforts to prevent outbreaks, lower healthcare costs, and boost public health. Vaccination programs boost demand for inactivated polio and rabies vaccines by enhancing awareness, funding, and coverage in high-risk areas. Mass campaigns and routine immunizations led by governments and health bodies sustain consistent uptake. For instance, in April 2024, according to the Pan American Health Organization (PAHO), a US-based specialized agency, the 22nd Vaccination Week in the Americas (VWA) with the theme Engage now to protect your future GetVax launched, aiming to increase vaccination coverage, especially in underserved areas, by administering over 65 million doses. The initiative focused on combating misinformation and enhancing access to vaccines through community engagement and tailored campaigns. Therefore, the growing demand for effective vaccination programs is driving the growth of the inactivated polio and rabies vaccines industry.

Key Players In The Global Inactivated Polio And Rabies Vaccines Market

Major companies operating in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, China National Pharmaceutical Group Co Ltd.

Global Inactivated Polio And Rabies Vaccines Market Trends and Insights

Major companies operating in the inactivated polio and rabies vaccines market are focused on developing advanced products, such as killed virus rabies vaccines, to improve immunogenicity and meet the rising global demand for effective disease prevention. Killed virus rabies vaccines are formulated using rabies virus that has been rendered non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without causing the disease, ensuring safety and effectiveness in both pre- and post-exposure prophylaxis. For instance, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for pre-exposure and post-exposure prophylaxis of rabies in all age groups. The vaccine, licensed in the UK based on extensive clinical data from over 13,000 individuals, has been widely used in more than 80 countries. Verorab provides an effective immunization option for travelers to high-risk countries and for treatment after rabies exposure, with clinical trials showing strong immune responses and long-lasting protection.

What Are Latest Mergers And Acquisitions In The Inactivated Polio And Rabies Vaccines Market?

In June 2024, Sanofi, a France-based manufacturer of inactivated polio vaccine, partnered with Biovac to empower Africa through local vaccine production. The partnership aims to establish sustainable local manufacturing of inactivated polio vaccines (IPV) in Africa, strengthen regional self-sufficiency, and support polio eradication efforts across over 40 African countries. Biovac is a South Africa-based biopharmaceutical company that specializes in developing vaccines for diseases that affect people in Africa.

Regional Insights

North America was the largest region in the inactivated polio and rabies vaccines market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Inactivated Polio And Rabies Vaccines Market?

The inactivated polio and rabies vaccines market consists of sales of combination vaccines containing inactivated polio vaccine (IPV), pre-exposure prophylaxis vaccines, and post-exposure prophylaxis (PEP) kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold to the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Inactivated Polio And Rabies Vaccines Market Report 2026?

The inactivated polio and rabies vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the inactivated polio and rabies vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.